HRES 1434 · 117th Congress · Health

Reaffirming the preemptive authority of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and the Public Health Service Act (42 U.S.C. 201 et seq.) (including regulations thereunder) with respect to State laws that inhibit access to or use of any reproductive health product.

Introduced 2022-10-14· Sponsored by Rep. Jones, Mondaire [D-NY-17]· House

Bill Progress

Introduced
Committee
House Vote
4
Senate
5
Enacted
Latest: Pursuant to the provisions of H. Res. 1529, H. Res. 1434 is considered passed House.(2022-12-21)

Plain Language Summary

[AI summary unavailable — showing source text] This resolution affirms that there is well-established authority for the Food and Drug Administration to approve, license, and otherwise regulate reproductive health products under the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act. The resolution also affirms that (1) such federal laws preempt (i.e., supersede conflicting state or local laws) any state or local laws that prohibit or limit access to or use of any reproductive health product, and (2) the Department of Justice has authority to enforce the preemptive effect of such federal laws by suing any state or political subdivision of a state that prohibits or limits access to or use of any reproductive health product.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (20)

20 Democrats